GLP-1 in New Hampshire (2026): Telehealth, Cost & PlexusDx Protocols | PlexusDx

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

If you live in New Hampshire and you’ve been searching for GLP-1 in 2026, the landscape just changed under your feet. As of January 1, 2026, NH Medicaid no longer covers GLP-1 medications when prescribed solely for weight loss, and several commercial plans in the state have followed with tighter prior authorization or full exclusion of weight-management indications. That leaves a large group of Granite Staters paying cash for the first time — and the cash-pay market in New Hampshire spans roughly $129/mo on the low end to $1,349/mo at retail brand pricing. This guide walks the actual paths a New Hampshire resident has in 2026: telehealth eligibility under NH law, what Medicaid still covers, the cash-pay providers serving NH, the local clinic option, and where the PlexusDx Microdose GLP-1 Protocol, Semaglutide Injection, and Tirzepatide Injection sit in that map. PlexusDx ships to all 50 states, including New Hampshire, with no membership and no contract.

Is telehealth GLP-1 legal in New Hampshire?

Yes. New Hampshire law allows a clinician–patient relationship to be established through telemedicine, and providers treating NH patients generally must hold an active New Hampshire license or comply with applicable interstate telehealth rules. GLP-1 medications — semaglutide, tirzepatide, liraglutide — are not DEA-scheduled controlled substances, so they fall under standard prescribing authority rather than the tighter rules that govern controlled drugs. NH SB252 further expanded telehealth prescribing flexibility, and the practical result is that most NH residents in 2026 can complete a full GLP-1 intake — medical history, BMI verification, lab review where applicable, and prescription — without ever driving to Manchester, Nashua, or Concord. PlexusDx Weight Management Protocols use this same framework: an asynchronous provider consultation for the majority of NH residents, with five other states (not NH) requiring a scheduled live consultation before prescribing.

What changed with NH Medicaid GLP-1 coverage in 2026?

Effective January 1, 2026, New Hampshire Medicaid stopped covering GLP-1 receptor agonists when the prescribing indication is obesity or weight loss alone. Coverage continues when the same medication is prescribed for type 2 diabetes, cardiovascular risk reduction in patients meeting label criteria, or other approved clinical indications — so a patient on Ozempic for diabetes is unaffected, while a patient on Wegovy strictly for weight loss lost coverage. Several commercial plans operating in NH have layered additional restrictions in the same window. If you received a coverage termination letter in late 2025 or early 2026, you are not alone: the change affected several thousand NH residents in the first quarter of 2026. The practical question becomes: what does cash-pay look like, and which lane fits your budget? PlexusDx’s entry-tier Microdose GLP-1 Protocol at $129/mo flat is one of the lowest cash-pay starting points available to NH residents who lost coverage and need to maintain therapy without disruption.

How much does GLP-1 cost in New Hampshire without insurance?

Cash-pay GLP-1 pricing in New Hampshire spans a wide range. Brand-name Wegovy runs roughly $1,349/month at retail; Zepbound’s Lilly Direct self-pay vials run roughly $499/month for most dose levels. Membership-plus-medication telehealth (Ro and similar) starts at a $39 first-month membership, then $149/month membership plus the medication cost itself. Compounded telehealth platforms cluster between $129 and $329/month depending on provider, dose, and commitment length. PlexusDx Weight Management Protocols are priced as follows for NH residents (cash-pay, no membership, all-inclusive of consultation, prescription, compounded medication, and shipping): Microdose GLP-1 Protocol at $129/mo flat, Semaglutide Oral from $249/mo, Semaglutide Injection at $149/mo, Tirzepatide Injection at $249/mo, Tirzepatide Oral at $279/mo, and GLP-Squared dual-compound at $249/mo. Annualized at the entry tier, the Microdose protocol totals $1,548/year — meaningfully below most NH competitor entry points and dramatically below brand-name retail.

Cash-pay GLP-1 options serving New Hampshire

Several telehealth platforms currently serve NH residents on a cash-pay basis. MEDVi advertises an all-inclusive compounded plan; Eden Health publishes a 3-month compounded semaglutide plan starting at $129 first month and $249/mo after; SkinnyRX lists compounded semaglutide from approximately $179/month; Ro’s membership-plus-medication path routes NH residents to FDA-approved Wegovy and Zepbound at branded pricing with insurance navigation included. PlexusDx fits between the cheapest entry tier and the brand-name route: cash-pay, no membership, no contract, with six prescription compounds across four mechanism classes (microdose, oral, injection, dual-compound) and an optional genetic baseline. NH residents who want the lowest cash-pay starting point should look at the Microdose GLP-1 Protocol; residents who want a weekly injection at competitive pricing should look at the Semaglutide Injection tier; residents who want the dual GIP/GLP-1 mechanism that drove the SURMOUNT trial outcomes should look at the Tirzepatide Injection tier.

Compounded vs FDA-approved GLP-1 — what NH residents actually get

This is the substantive medication difference and it’s worth understanding before signing up for any NH provider. FDA-approved branded GLP-1 medications — Wegovy and Ozempic (semaglutide), Zepbound and Mounjaro (tirzepatide), Saxenda (liraglutide), Rybelsus (oral semaglutide), Trulicity, Victoza — have undergone full FDA review for safety and efficacy as finished drug products. Compounded semaglutide and tirzepatide are prepared by licensed U.S. compounding pharmacies (503A or 503B-registered) using pharmaceutical-grade active ingredients, but compounded products are not FDA-approved finished drugs — they are pharmacy-prepared formulations of the same active ingredient. PlexusDx Weight Management Protocols use compounded semaglutide and tirzepatide from licensed U.S. compounding pharmacies. Ro’s primary path dispenses FDA-approved branded products. The compounded vs branded choice is not about effectiveness of the active ingredient — it is about FDA approval status of the finished product, supply consistency, and which regulatory framework governs your medication. NH residents weighing this trade-off should also note that the boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies, regardless of whether the formulation is branded or compounded.

Local New Hampshire clinics vs telehealth

Telehealth is not for everyone. Some NH residents prefer in-person injection coaching, hands-on monitoring, or face-to-face provider relationships, and there are medical weight-loss clinics concentrated in southern NH (Manchester, Nashua, Salem, Bedford, Portsmouth) that prescribe GLP-1 medications in a brick-and-mortar setting. Expect higher monthly costs at most local clinics — in-person practice overhead, lab work billed separately, and longer wait times for new-patient appointments are typical. Telehealth via PlexusDx and similar platforms ships medication directly to NH residents’ addresses with no in-person visit required for the majority of dose ranges. For NH residents who want a hybrid — convenient telehealth pricing with a measurable biological baseline — the Precision Peptide Genetic Test ($298 standalone, or $99 as an add-on after the first month of any PlexusDx protocol) maps 48 genes and 57 variants across 14 health pathways, including 34 weight-management insights and the GIPR rs1800437 variant linked to differential GLP-1 response.

How to verify any New Hampshire GLP-1 provider before you pay

Before you hand over a credit card, run the four-step verification: (1) confirm the prescribing clinician is licensed in NH through the NH Office of Professional Licensure and Certification (OPLC) at oplc.nh.gov; (2) confirm the dispensing pharmacy is a licensed 503A or FDA-registered 503B facility — reputable telehealth providers will name their pharmacy on request; (3) confirm a real medical screening occurs before prescribing — intake forms only, with no clinician review of weight, BMI, comorbidities, and contraindications, is a red flag; (4) confirm a clear cancellation policy with no hidden multi-month commitment. PlexusDx publishes its protocol pricing, lists its compounded medication structure, runs every NH intake through a licensed clinical team, and has no membership fee — cancellation is straightforward through the customer portal.

Why a genetic baseline matters before your first NH GLP-1 dose

GLP-1 response varies meaningfully across patients. Variants in GLP1R (the GLP-1 receptor itself), FTO (appetite regulation), MC4R (satiety signaling), TCF7L2 (insulin response), and GIPR (the secondary receptor that tirzepatide engages) are associated with measurably different response patterns to semaglutide and tirzepatide. NH residents who’ve seen one family member lose 20% of body weight on a low semaglutide dose while another stalls at 5% on the same regimen have already observed this variation. The Precision Peptide Genetic Test maps the relevant variants so the prescribing clinician knows whether a faster-than-typical titration, a slower one, or a tirzepatide-first approach is more likely to fit your biology before week one. Most NH cash-pay providers do not perform this step — they start from a population-average titration schedule and adjust based on subjective tolerability. PlexusDx anchors that conversation to a measurable genetic baseline, which is particularly useful for NH residents starting therapy after losing Medicaid coverage and trying to maximize results from a tighter monthly budget.

Frequently asked questions

Can I get GLP-1 medication via telehealth in New Hampshire?

Yes. New Hampshire law permits a clinician–patient relationship to be established through telemedicine, and GLP-1 medications are not DEA-scheduled controlled substances. Providers treating NH patients must hold a NH license or comply with applicable interstate telehealth rules. PlexusDx Weight Management Protocols ship to NH with an asynchronous provider consultation included.

Does New Hampshire Medicaid cover GLP-1 for weight loss in 2026?

No. As of January 1, 2026, NH Medicaid no longer covers GLP-1 medications prescribed solely for weight loss. Coverage continues for type 2 diabetes, cardiovascular risk reduction, and other approved clinical indications. NH residents who lost coverage typically move to cash-pay telehealth such as the PlexusDx Microdose GLP-1 Protocol at $129/mo flat.

What is the cheapest GLP-1 program available in New Hampshire?

The PlexusDx Microdose GLP-1 Protocol at $129/mo flat is one of the lowest cash-pay starting points available to NH residents in 2026. Other compounded telehealth programs cluster between $129 and $329/month depending on provider, dose, and commitment length. Brand-name Wegovy at retail runs roughly $1,349/month.

How much does GLP-1 cost in New Hampshire without insurance?

Cash-pay GLP-1 pricing in NH ranges from $129/month at the entry tier through PlexusDx’s Microdose GLP-1 Protocol up to $1,349/month for brand-name Wegovy at retail. Compounded semaglutide and tirzepatide telehealth providers, including PlexusDx, generally fall between those ends, with PlexusDx Semaglutide Injection at $149/mo and Tirzepatide Injection at $249/mo.

Is compounded GLP-1 FDA-approved?

No. Compounded semaglutide and tirzepatide are prepared by licensed U.S. compounding pharmacies but are not FDA-approved finished drug products. Only branded products such as Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda, Rybelsus, Trulicity, and Victoza carry FDA approval as finished medications. PlexusDx uses licensed U.S. compounding pharmacies for its protocols.

Can I use HSA or FSA to pay for GLP-1 in New Hampshire?

HSA and FSA funds may be used for GLP-1 medications when prescribed for a qualified medical purpose. Eligibility and reimbursement vary by plan administrator and provider, so confirm with your specific plan before assuming coverage. PlexusDx provides receipts that NH residents can submit to their HSA or FSA administrator.

What if my NH insurance just stopped covering my GLP-1?

Cash-pay compounded telehealth programs typically start in the $129–$179/month range, which is dramatically below brand-name retail. The PlexusDx Microdose GLP-1 Protocol at $129/mo flat and Semaglutide Injection at $149/mo are designed for exactly this scenario — continuity of therapy without insurance, no membership fee, and shipping included.

Related reading on PlexusDx

Related reading on PlexusDx: GLP-1 Cost, Cheapest GLP-1, Semaglutide Cost, Tirzepatide Costs.

Disclaimer: This article is educational and is not medical advice. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols. Pricing for New Hampshire competitor providers and brand-name medications is based on each provider’s published rates as of April 2026; actual costs may vary by state, plan, and individual eligibility. PlexusDx does not sell, prescribe, or recommend any therapeutic peptide outside the GLP-1 category covered by its protocols. Discuss any GLP-1 medication decision with a licensed clinician.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.